Mylan has announced the launch of 200mg Doxycycline Hyclate Delayed-Release (DR) Tablets USP, the generic version of Mayne’s Doryx.

Doryx is a tetracycline antibiotic indicated as adjunct treatment in severe acne, the treatment of tetracycline-susceptible infections including respiratory, genitourinary, rickettsial, trachoma, and for postexposure prophylaxis and treatment of anthrax. It has bacteriostatic activity against a broad range of Gram-positive and Gram-negative bacteria.

For more information call (724) 514-1800 or visit